Virginia Commonwealth University Health System Authority

Virginia Commonwealth University Health System Authority was paid $658.49M by Medicaid between Jan 2018 and Dec 2024, across 1217 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 18% of everything it billed.

Compared with peers

Next to other Psychiatric Hospital Unit providers in Virginia

Rank by total paid#1 of 5

Median peer was paid$15K

This provider vs. median43,772×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	870,291	$45.74M
2019	1,257,745	$77.06M
2020	990,457	$71.74M
2021	1,310,477	$91.83M
2022	1,397,344	$110.96M
2023	1,459,009	$149.79M
2024incomplete	1,186,608	$111.37M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	18%	651,324	484,205	$120.56M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.3%	115,061	97,838	$28.32M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.0%	160,141	126,648	$26.37M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	3.7%	86,272	32,415	$24.24M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.9%	83,799	68,954	$19.42M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.8%	116,764	97,934	$18.49M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.5%	66,291	54,864	$16.16M
96110	Developmental screening, with scoring and documentation, per standardized instrument	2.4%	25,809	24,105	$15.80M
96361	Intravenous infusion, hydration; each additional hour	2.2%	34,999	24,947	$14.71M
J9271	Injection, pembrolizumab, 1 mg	2.1%	2,346	1,385	$14.11M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1.5%	5,152	2,168	$9.94M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.4%	154,465	57,444	$9.40M

1205 more codes

G0378	Hospital observation service, per hour	1.4%	49,357	$9.24M
41899	Unlisted procedure, dentoalveolar structures	1.3%	4,470	$8.76M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.1%	47,510	$7.22M
77386		1.0%	11,560	$6.65M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	14,180	$6.32M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	84,511	$6.29M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	16,656	$6.20M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	38,832	$6.17M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	19,903	$5.42M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	27,229	$5.40M
70450	Computed tomography, head or brain; without contrast material	<1%	21,347	$5.40M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	3,543	$5.36M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	6,377	$4.89M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	10,498	$4.77M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	21,019	$4.76M
20610		<1%	12,876	$3.59M
77412		<1%	7,428	$3.26M
96415		<1%	7,430	$3.09M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,581	$3.05M
59899		<1%	4,135	$3.04M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	21,721	$3.03M
J0178	Injection, aflibercept, 1 mg	<1%	2,359	$2.87M
90837	Psychotherapy session, about an hour	<1%	15,372	$2.81M
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	15,292	$2.79M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	19,309	$2.78M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,123	$2.75M
99215	Doctor's office visit, returning patient (complex)	<1%	16,860	$2.71M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	3,482	$2.67M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,937	$2.63M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	15,412	$2.63M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,829	$2.55M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	53,181	$2.51M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	10,066	$2.46M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	4,298	$2.45M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	21,101	$2.39M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	8,426	$2.33M
J2505	Injection, pegfilgrastim, 6 mg	<1%	1,172	$2.22M
71275	Computed tomographic angiography, chest, with contrast material	<1%	8,825	$2.19M
97161		<1%	15,736	$2.16M
43235		<1%	2,809	$2.13M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	36,174	$2.10M
93308		<1%	4,504	$2.09M
52000		<1%	1,929	$2.03M
76770		<1%	8,911	$2.01M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	15,159	$1.96M
93458		<1%	872	$1.96M
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	744	$1.96M
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	977	$1.96M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,637	$1.95M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	49,610	$1.84M
36430		<1%	7,566	$1.81M
92526		<1%	24,270	$1.77M
J0485	Injection, belatacept, 1 mg	<1%	3,276	$1.73M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	14,199	$1.72M
90834	Psychotherapy session, about 45 minutes	<1%	10,846	$1.71M
74183		<1%	3,835	$1.64M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,413	$1.64M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	5,425	$1.63M
97162		<1%	9,209	$1.58M
67028	Intravitreal injection of a pharmacologic agent	<1%	5,377	$1.54M
80048	Basic metabolic panel (calcium, ionized)	<1%	191,528	$1.53M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,195	$1.50M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	4,202	$1.49M
80053	Comprehensive metabolic panel	<1%	191,489	$1.40M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,175	$1.40M
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	775	$1.39M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	8,868	$1.38M
64615		<1%	2,846	$1.37M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	31,722	$1.34M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,376	$1.33M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	11,236	$1.30M
92551		<1%	8,751	$1.29M
31575		<1%	4,108	$1.29M
J9035	Injection, bevacizumab, 10 mg	<1%	887	$1.27M
92523		<1%	4,258	$1.25M
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	11,293	$1.22M
36561		<1%	625	$1.20M
97535	Self-care/home management training, each 15 minutes	<1%	23,104	$1.19M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	3,905	$1.19M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,990	$1.17M
97116		<1%	20,619	$1.16M
J2357	Injection, omalizumab, 5 mg	<1%	1,330	$1.15M
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	8,444	$1.14M
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	8,709	$1.10M
87536		<1%	15,172	$1.08M
90791	Psychiatric diagnostic evaluation	<1%	4,420	$1.06M
49083		<1%	1,434	$1.06M
70498		<1%	6,223	$1.05M
76830	Ultrasound, transvaginal	<1%	6,224	$1.01M
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	80,720	$1.00M
90792	Psychiatric diagnostic evaluation with medical services	<1%	3,653	$993K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	12,991	$977K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	2,703	$963K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	13,146	$935K
95816		<1%	2,532	$923K
36512		<1%	459	$913K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,361	$911K
97163		<1%	2,932	$897K
72141		<1%	3,591	$860K
54161		<1%	519	$851K
59025	Fetal non-stress test	<1%	3,282	$846K
93017		<1%	5,407	$830K
64643		<1%	1,593	$822K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	9,355	$801K
38222		<1%	1,358	$794K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,129	$792K
93971		<1%	5,731	$784K
93325		<1%	6,919	$779K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	201	$778K
71250		<1%	7,341	$772K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,334	$739K
92610		<1%	3,503	$728K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	235	$715K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	4,920	$714K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	414	$708K
76819	Fetal biophysical profile; without non-stress testing	<1%	5,681	$708K
97165		<1%	5,958	$706K
64483		<1%	973	$705K
J2323	Injection, natalizumab, 1 mg	<1%	254	$701K
64642		<1%	2,226	$701K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	4,578	$672K
75561		<1%	1,418	$644K
70491		<1%	3,111	$642K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	2,632	$640K
99177		<1%	5,000	$639K
70496		<1%	2,632	$632K
76642		<1%	3,910	$631K
90832	Psychotherapy session, about 30 minutes	<1%	4,588	$630K
90686		<1%	42,951	$621K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	38,305	$619K
93970		<1%	3,531	$617K
76801		<1%	4,453	$599K
90472	Immunization administration, each additional vaccine (list separately)	<1%	27,478	$599K
97803		<1%	6,110	$596K
77336		<1%	5,236	$588K
90651		<1%	9,025	$587K
93975		<1%	3,709	$570K
96367		<1%	7,517	$565K
95806		<1%	678	$559K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	3,769	$549K
76536		<1%	3,622	$549K
C9257	Injection, bevacizumab, 0.25 mg	<1%	955	$545K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	35,524	$535K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	2,609	$535K
42830		<1%	177	$525K
90677		<1%	6,239	$519K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	264,397	$518K
17250		<1%	1,255	$510K
77334		<1%	2,356	$510K
71046	Radiologic examination, chest; 2 views	<1%	42,663	$509K
77301		<1%	356	$507K
72197		<1%	1,389	$503K
97166		<1%	2,817	$495K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	10,921	$491K
95819		<1%	1,340	$489K
95708		<1%	691	$477K
83880		<1%	29,479	$469K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	38,304	$465K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	239	$462K
20550		<1%	1,571	$459K
90670		<1%	25,023	$452K
73221		<1%	1,611	$449K
74178		<1%	1,516	$438K
94010		<1%	11,581	$435K
77002		<1%	2,729	$418K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,101	$417K
97167		<1%	1,673	$415K
31231		<1%	1,790	$411K
58300		<1%	1,587	$405K
96161		<1%	13,186	$402K
97755		<1%	1,697	$395K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	95,720	$392K
J9299	Injection, nivolumab, 1 mg	<1%	146	$388K
J2350	Injection, ocrelizumab, 1 mg	<1%	13	$387K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	23,875	$383K
96409		<1%	4,001	$378K
88185		<1%	7,063	$378K
77295		<1%	382	$378K
93451		<1%	158	$377K
95886		<1%	2,235	$375K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	46,034	$373K
85027		<1%	117,168	$364K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	27,133	$362K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	618	$361K
99173		<1%	5,716	$352K
76942		<1%	4,832	$351K
95885		<1%	2,003	$347K
J2353	Injection, octreotide, depot form for intramuscular injection, 1 mg	<1%	125	$346K
76604		<1%	3,421	$340K
90715		<1%	14,994	$338K
80197		<1%	21,067	$334K
76937		<1%	4,427	$332K
80061	Lipid panel	<1%	48,654	$330K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	1,787	$329K
72158		<1%	1,529	$323K
95700		<1%	1,572	$315K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	22,680	$313K
97016		<1%	8,407	$312K
36415	Collection of venous blood by venipuncture	<1%	260,919	$307K
96133		<1%	1,280	$306K
J0475	Injection, baclofen, 10 mg	<1%	695	$301K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	191	$301K
96160		<1%	2,572	$299K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,852	$298K
93296		<1%	8,916	$292K
96416		<1%	665	$291K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	220	$290K
83735		<1%	115,256	$290K
80076		<1%	33,627	$290K
87522	Neg quan hep c or qual rna	<1%	9,455	$288K
97602		<1%	850	$288K
74174		<1%	770	$284K
90648		<1%	24,846	$281K
93922		<1%	3,020	$279K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,508	$278K
97597		<1%	3,054	$277K
96130		<1%	645	$274K
77001		<1%	2,103	$273K
95716		<1%	661	$272K
97802		<1%	3,095	$271K
76775		<1%	1,748	$270K
76870		<1%	1,954	$270K
11981		<1%	717	$270K
20680		<1%	258	$268K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	122	$268K
97032		<1%	5,032	$260K
74230		<1%	1,730	$257K
83970		<1%	11,557	$257K
70486		<1%	2,970	$252K
84443	Thyroid stimulating hormone (TSH)	<1%	56,094	$249K
87632		<1%	2,058	$247K
62323		<1%	318	$242K
95811		<1%	388	$241K
72125	Computed tomography, cervical spine; without contrast material	<1%	8,546	$241K
11982		<1%	488	$241K
73610		<1%	14,223	$239K
97760		<1%	5,102	$238K
86833		<1%	2,131	$238K
36591		<1%	13,765	$235K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	658	$233K
12001		<1%	756	$232K
87653		<1%	4,890	$231K
10060		<1%	1,219	$229K
76882		<1%	1,808	$227K
72156		<1%	1,403	$225K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	946	$224K
96137		<1%	1,264	$221K
86832		<1%	2,125	$220K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	355	$217K
86780		<1%	20,693	$217K
43762		<1%	776	$217K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,127	$215K
76813		<1%	2,221	$212K
97035		<1%	4,825	$211K
94726		<1%	4,317	$210K
73700		<1%	1,646	$210K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,682	$209K
94729		<1%	5,177	$204K
77280		<1%	595	$202K
74018		<1%	7,908	$200K
J1756	Injection, iron sucrose, 1 mg	<1%	5,192	$199K
83655		<1%	8,671	$198K
93880		<1%	1,615	$197K
58301		<1%	837	$196K
J2997	Injection, alteplase recombinant, 1 mg	<1%	1,768	$195K
51784		<1%	753	$194K
76498		<1%	651	$193K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	1,562	$193K
92015	Determination of refractive state	<1%	20,903	$189K
29405		<1%	634	$188K
72146		<1%	959	$186K
76820		<1%	1,562	$183K
73630		<1%	17,501	$183K
94060		<1%	2,475	$183K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	15,110	$181K
77066	Tomosynthesis, mammo	<1%	2,966	$181K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,780	$181K
83036	Hemoglobin; glycosylated (A1C)	<1%	61,687	$178K
97018		<1%	6,805	$178K
86830		<1%	2,198	$177K
78264		<1%	382	$176K
77300		<1%	1,842	$175K
96450		<1%	379	$175K
86803		<1%	19,820	$174K
95782		<1%	154	$174K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	185	$170K
62370		<1%	1,161	$164K
73030		<1%	14,038	$162K
57454		<1%	271	$161K
93350		<1%	489	$160K
96523		<1%	3,500	$160K
96132		<1%	1,351	$157K
96116		<1%	776	$156K
90723		<1%	17,033	$155K
20552		<1%	589	$155K
88142		<1%	9,158	$155K
90633		<1%	14,418	$152K
90870		<1%	351	$151K
93926		<1%	1,477	$151K
J9312	Injection, rituximab, 10 mg	<1%	96	$151K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	421	$149K
72040		<1%	6,229	$149K
87799		<1%	5,560	$146K
86831		<1%	2,127	$146K
90734		<1%	6,231	$146K
52310		<1%	171	$145K
72100		<1%	9,960	$145K
92083		<1%	4,801	$145K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	18,918	$144K
76818		<1%	1,058	$144K
77080		<1%	1,350	$143K
12011		<1%	536	$142K
71045	Radiologic examination, chest; single view	<1%	26,072	$140K
87497		<1%	3,294	$140K
77338		<1%	389	$139K
86360		<1%	12,933	$139K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	5,780	$138K
88307		<1%	3,846	$138K
49452		<1%	209	$137K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,667	$135K
20605		<1%	478	$133K
86850		<1%	39,830	$133K
85610		<1%	55,610	$133K
51728		<1%	367	$133K
86359		<1%	12,946	$132K
90636		<1%	1,364	$132K
84484		<1%	52,195	$131K
73590		<1%	8,655	$131K
73562		<1%	8,486	$129K
73564		<1%	12,639	$128K
93304		<1%	320	$128K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,326	$127K
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	<1%	240	$127K
86787		<1%	6,452	$127K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	997	$125K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	49,450	$125K
77065	Tomosynthesis, mammo	<1%	2,077	$124K
77290		<1%	316	$124K
86762		<1%	6,195	$123K
82728		<1%	27,164	$122K
87086	Culture, bacterial; quantitative colony count, urine	<1%	45,019	$121K
96401		<1%	1,847	$120K
71271		<1%	804	$120K
86923		<1%	4,579	$120K
73560		<1%	9,592	$119K
69210		<1%	2,153	$119K
87040		<1%	9,243	$119K
73130		<1%	9,865	$118K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	12,594	$117K
87641		<1%	4,517	$117K
90681		<1%	13,867	$116K
72157		<1%	693	$115K
93925		<1%	856	$115K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	71,177	$115K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	13,365	$113K
58100		<1%	485	$113K
86900		<1%	42,547	$112K
97164		<1%	773	$112K
91322		<1%	2,118	$112K
70543		<1%	287	$110K
11102		<1%	270	$109K
73502		<1%	10,152	$108K
43248		<1%	125	$106K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	443	$105K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	248	$104K
91200		<1%	960	$103K
92134		<1%	14,545	$103K
84702		<1%	24,307	$102K
80305		<1%	24,364	$100K
84439		<1%	20,742	$100K
88237		<1%	1,385	$99K
82105		<1%	9,777	$99K
81370		<1%	274	$98K
92020		<1%	317	$98K
83605		<1%	33,031	$96K
90710		<1%	5,420	$95K
0001A		<1%	4,207	$95K
82607		<1%	16,353	$94K
96139		<1%	570	$93K
86829		<1%	631	$93K
87486		<1%	13,125	$93K
0042T		<1%	552	$90K
90716		<1%	6,343	$90K
52356		<1%	16	$88K
0002A		<1%	2,792	$86K
99204	Doctor's office visit, new patient (more involved)	<1%	657	$85K
43760		<1%	239	$85K
91300		<1%	8,127	$84K
73110		<1%	6,590	$84K
31615		<1%	43	$81K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	3,719	$81K
19083		<1%	48	$81K
90474		<1%	5,587	$80K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	5,124	$79K
36590		<1%	82	$79K
92607		<1%	275	$79K
96402		<1%	1,984	$79K
97010		<1%	2,085	$78K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	83	$78K
82784		<1%	8,998	$77K
57420		<1%	126	$76K
90707		<1%	7,498	$76K
97763		<1%	1,640	$75K
66982		<1%	46	$75K
87340		<1%	20,813	$74K
74455		<1%	321	$74K
77073		<1%	4,803	$73K
87581		<1%	13,124	$73K
87517		<1%	2,151	$73K
86901		<1%	42,395	$73K
95951		<1%	156	$71K
64450		<1%	190	$70K
90671		<1%	678	$69K
L8699	Prosthetic implant, not otherwise specified	<1%	1,330	$69K
88341		<1%	3,078	$69K
J7050	Infusion, normal saline solution, 250 cc	<1%	23,469	$69K
76881		<1%	429	$69K
70487		<1%	170	$68K
20553		<1%	311	$68K
81001		<1%	77,848	$68K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	9,455	$68K
77470		<1%	78	$67K
54150		<1%	28	$67K
82248		<1%	45,623	$67K
86003		<1%	3,588	$66K
88262		<1%	1,296	$66K
J3490	Unclassified drugs	<1%	73,521	$66K
90698		<1%	6,493	$65K
J9070	Cyclophosphamide, 100 mg	<1%	606	$65K
73552		<1%	5,985	$65K
29075		<1%	152	$64K
73070		<1%	3,204	$64K
99203	Doctor's office visit, new patient (routine)	<1%	518	$63K
84100		<1%	42,985	$63K
86480		<1%	3,842	$63K
90700		<1%	6,771	$63K
92504		<1%	407	$63K
70355		<1%	1,287	$63K
87507		<1%	439	$62K
78451		<1%	106	$62K
73090		<1%	5,226	$61K
72170		<1%	4,429	$61K
73080		<1%	4,355	$61K
92611		<1%	1,502	$61K
90656		<1%	3,789	$60K
J2704	Injection, propofol, 10 mg	<1%	92,516	$60K
93321		<1%	1,168	$59K
90999	Dialysis (unlisted procedure)	<1%	587	$59K
96375	Therapeutic injection; each additional sequential IV push	<1%	43,993	$58K
0064U		<1%	6,258	$58K
87902		<1%	767	$58K
92133		<1%	6,500	$57K
84466		<1%	20,157	$57K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	2,067	$57K
36224		<1%	12	$57K
62322		<1%	144	$57K
77049		<1%	80	$57K
95911		<1%	329	$57K
95117		<1%	1,619	$56K
88342		<1%	6,188	$56K
80321		<1%	1,636	$56K
96411		<1%	3,003	$55K
86140		<1%	27,801	$54K
96127		<1%	1,058	$53K
83021		<1%	7,605	$53K
95910		<1%	424	$53K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	36,764	$53K
86255		<1%	2,413	$53K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	50,191	$53K
70544		<1%	210	$52K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	62,240	$52K
92002		<1%	404	$52K
90732		<1%	2,408	$51K
93798		<1%	341	$50K
11100		<1%	133	$50K
36592		<1%	3,735	$50K
90480		<1%	2,524	$50K
73100		<1%	3,070	$49K
70320		<1%	1,255	$49K
36558		<1%	34	$49K
83540		<1%	22,694	$49K
99354		<1%	1,074	$49K
J7030	Infusion, normal saline solution , 1000 cc	<1%	49,709	$49K
86235		<1%	2,559	$48K
74240		<1%	302	$48K
72131		<1%	572	$48K
88184		<1%	2,899	$47K
88275		<1%	1,034	$47K
84153		<1%	6,341	$46K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	32,985	$46K
72110		<1%	2,007	$46K
84403		<1%	4,249	$45K
88360		<1%	1,787	$45K
99188		<1%	2,223	$45K
95913		<1%	239	$45K
81003		<1%	31,774	$45K
83615		<1%	12,276	$44K
88271		<1%	1,106	$44K
54300		<1%	14	$43K
82565		<1%	16,831	$43K
72190		<1%	1,074	$42K
86706		<1%	10,136	$42K
10005		<1%	87	$42K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	21,764	$42K
92609		<1%	683	$41K
J3262	Injection, tocilizumab, 1 mg	<1%	59	$41K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,061	$41K
84402		<1%	1,982	$41K
73200		<1%	258	$40K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	1,111	$40K
76512		<1%	265	$40K
64493		<1%	45	$40K
85730		<1%	21,099	$39K
80364		<1%	3,278	$39K
72082		<1%	3,290	$39K
73060		<1%	3,250	$38K
76000		<1%	2,499	$38K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	41	$38K
96040		<1%	258	$38K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	265	$38K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	5,747	$38K
64416		<1%	123	$37K
73140		<1%	2,896	$37K
80164		<1%	2,939	$37K
82948		<1%	39,552	$36K
77072		<1%	1,102	$36K
84146		<1%	2,570	$36K
85018		<1%	12,957	$35K
82247		<1%	22,850	$35K
81025		<1%	26,730	$35K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,345	$35K
82533		<1%	2,246	$35K
J0690	Injection, cefazolin sodium, 500 mg	<1%	27,199	$35K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,847	$35K
J8540	Dexamethasone, oral, 0.25 mg	<1%	7,591	$34K
84425		<1%	2,758	$34K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	1,956	$34K
73620		<1%	2,613	$34K
84156		<1%	17,297	$34K
G0008	Administration of influenza virus vaccine	<1%	7,064	$34K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,970	$34K
82805		<1%	11,464	$34K
81329		<1%	1,164	$33K
77062		<1%	963	$33K
86704		<1%	7,666	$33K
36593		<1%	170	$33K
43249		<1%	41	$33K
90746		<1%	1,474	$33K
54640		<1%	14	$32K
76827		<1%	1,060	$32K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	9,581	$32K
86644		<1%	2,132	$32K
C1769	Guide wire	<1%	12,077	$32K
86334		<1%	3,030	$30K
90696		<1%	2,731	$30K
74221		<1%	245	$30K
95874		<1%	1,015	$30K
12002		<1%	114	$30K
86160		<1%	3,986	$30K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	80	$30K
95909		<1%	214	$30K
93799		<1%	3,415	$30K
96138		<1%	565	$29K
82746		<1%	8,733	$29K
82977		<1%	2,352	$29K
64644		<1%	184	$29K
73600		<1%	2,174	$29K
90662		<1%	2,870	$29K
88312		<1%	1,481	$29K
72070		<1%	1,874	$28K
0124A		<1%	2,011	$28K
82670		<1%	1,753	$28K
97542		<1%	507	$28K
87631		<1%	1,351	$28K
91312		<1%	2,037	$28K
86665		<1%	1,290	$28K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	10,535	$27K
92522		<1%	66	$27K
49450		<1%	35	$27K
96376		<1%	20,421	$27K
87077		<1%	15,227	$26K
95953		<1%	75	$26K
86038		<1%	6,091	$26K
83516		<1%	1,893	$26K
85379		<1%	4,176	$26K
29826		<1%	27	$26K
86870		<1%	1,171	$26K
88313		<1%	3,101	$25K
94618		<1%	169	$25K
83690		<1%	33,859	$25K
87529		<1%	1,098	$25K
88304		<1%	3,046	$25K
86922		<1%	816	$25K
80177		<1%	3,373	$25K
86708		<1%	4,516	$25K
95970		<1%	469	$25K
87640		<1%	3,889	$25K
81382		<1%	200	$25K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	3,766	$24K
86825		<1%	198	$24K
91321		<1%	472	$24K
0100U		<1%	1,069	$24K
72050		<1%	1,391	$24K
82785		<1%	4,167	$23K
88143		<1%	1,257	$23K
83001		<1%	2,250	$23K
87081		<1%	7,281	$23K
77012		<1%	414	$22K
87070		<1%	8,571	$22K
85652		<1%	24,785	$22K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	10,186	$22K
94660		<1%	97	$21K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	2,877	$21K
80320		<1%	3,374	$21K
87075		<1%	3,384	$21K
74019		<1%	1,971	$21K
J2545	Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg	<1%	60	$21K
70480		<1%	111	$21K
94621		<1%	148	$21K
99406		<1%	762	$21K
87184		<1%	11,197	$21K
A9609	Fludeoxyglucose f18 up to 15 millicuries	<1%	103	$21K
97014		<1%	489	$20K
87210		<1%	4,779	$20K
82043		<1%	11,251	$20K
99153	Mod sedat endo service >5yrs	<1%	3,426	$20K
82950		<1%	3,850	$20K
96417		<1%	4,610	$19K
J3315	Injection, triptorelin pamoate, 3.75 mg	<1%	50	$19K
93225		<1%	461	$19K
G0009	Administration of pneumococcal vaccine	<1%	2,294	$19K
86902		<1%	2,072	$19K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	491	$19K
20611		<1%	58	$19K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	37	$18K
93320		<1%	4,160	$18K
73000		<1%	1,014	$18K
51700		<1%	50	$18K
96368		<1%	2,704	$18K
80323		<1%	1,123	$18K
88311		<1%	1,933	$18K
83002		<1%	1,646	$17K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	26,257	$17K
96121		<1%	30	$17K
73120		<1%	1,194	$17K
82103		<1%	1,354	$17K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	17,309	$17K
87900		<1%	390	$17K
89051		<1%	4,469	$17K
95076		<1%	27	$17K
84450		<1%	26,462	$16K
36581		<1%	20	$16K
74220		<1%	394	$16K
59841		<1%	71	$16K
82947		<1%	5,784	$16K
88173		<1%	732	$16K
70250		<1%	1,310	$16K
11900		<1%	52	$16K
73718		<1%	62	$16K
64494		<1%	38	$16K
J3489	Injection, zoledronic acid, 1 mg	<1%	428	$16K
J1644	Injection, heparin sodium, per 1000 units	<1%	16,777	$16K
83520		<1%	3,826	$16K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	39,811	$15K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,747	$15K
10061		<1%	60	$15K
99152		<1%	4,215	$15K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	287	$15K
84520		<1%	3,739	$14K
82378		<1%	2,245	$14K
99496		<1%	107	$14K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	895	$14K
84480		<1%	3,588	$14K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	3,345	$14K
C1889	Implantable/insertable device, not otherwise classified	<1%	3,392	$14K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,647	$14K
97039		<1%	280	$14K
80348		<1%	1,844	$13K
86805		<1%	151	$13K
0004A		<1%	709	$13K
87901		<1%	196	$13K
84460		<1%	24,026	$13K
C1781	Mesh (implantable)	<1%	53	$13K
84270		<1%	1,988	$13K
84165		<1%	3,847	$13K
84207		<1%	1,641	$13K
73222		<1%	13	$13K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	17,144	$13K
86355		<1%	1,177	$13K
0012A		<1%	470	$13K
81479	Unlisted molecular pathology procedure	<1%	72	$12K
92608		<1%	76	$12K
85049		<1%	1,568	$12K
93290		<1%	97	$12K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	5,067	$12K
95974		<1%	53	$12K
87205		<1%	11,388	$12K
C9399	Unclassified drugs or biologicals	<1%	1,277	$12K
91301		<1%	876	$12K
95713		<1%	34	$12K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	83	$12K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	109	$12K
86481		<1%	745	$12K
86709		<1%	1,446	$12K
84630		<1%	1,314	$12K
92136		<1%	655	$12K
86256		<1%	848	$12K
74241		<1%	73	$12K
36416		<1%	9,076	$11K
C1726	Catheter, balloon dilatation, non-vascular	<1%	1,168	$11K
91308		<1%	747	$11K
83921		<1%	1,384	$11K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,694	$11K
99495		<1%	223	$11K
82525		<1%	1,628	$11K
81243		<1%	286	$11K
86304		<1%	544	$11K
51600		<1%	40	$11K
51798		<1%	3,373	$11K
74170		<1%	49	$11K
Q0221	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg	<1%	284	$10K
64721		<1%	16	$10K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	49	$10K
80050	General health panel	<1%	740	$10K
93242		<1%	366	$10K
0011A		<1%	438	$10K
93226		<1%	394	$10K
82040		<1%	5,236	$10K
36000		<1%	1,174	$10K
95912		<1%	77	$10K
92250		<1%	1,241	$10K
82550		<1%	7,909	$10K
86592		<1%	3,554	$10K
82390		<1%	1,148	$10K
90750		<1%	61	$10K
94642		<1%	420	$10K
88344		<1%	400	$9K
36589		<1%	63	$9K
J1750	Injection, iron dextran, 50 mg	<1%	96	$9K
81206		<1%	82	$9K
84305		<1%	635	$9K
93750		<1%	262	$9K
82677		<1%	524	$9K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	339	$9K
85046		<1%	8,600	$9K
92310		<1%	109	$9K
86352		<1%	684	$9K
J9045	Injection, carboplatin, 50 mg	<1%	1,630	$9K
82627		<1%	903	$9K
93886		<1%	46	$9K
88108		<1%	1,564	$9K
51741		<1%	726	$9K
84550		<1%	6,265	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	8,709	$8K
83993		<1%	680	$8K
95977		<1%	45	$8K
80354		<1%	2,422	$8K
92025		<1%	128	$8K
82951		<1%	409	$8K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	4,497	$8K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	302	$8K
80183		<1%	809	$8K
95812		<1%	13	$8K
29581		<1%	31	$8K
20526		<1%	17	$8K
20206		<1%	15	$8K
11104		<1%	19	$8K
87116		<1%	707	$8K
76825		<1%	118	$8K
59425		<1%	58	$8K
93270		<1%	345	$7K
20600		<1%	29	$7K
74022		<1%	860	$7K
84075		<1%	18,418	$7K
99195		<1%	172	$7K
86777		<1%	499	$7K
96136		<1%	1,417	$7K
0003A		<1%	380	$7K
90744		<1%	861	$7K
72072		<1%	504	$7K
90682		<1%	218	$7K
90381		<1%	192	$7K
85045		<1%	5,673	$7K
82610		<1%	1,933	$7K
91320		<1%	120	$7K
86147		<1%	344	$7K
51797		<1%	491	$7K
84163		<1%	737	$7K
J1170	Injection, hydromorphone, up to 4 mg	<1%	21,583	$6K
82150		<1%	3,028	$6K
86336		<1%	1,681	$6K
87102		<1%	2,075	$6K
80203		<1%	476	$6K
86376		<1%	574	$6K
84134		<1%	1,680	$6K
81002		<1%	5,866	$6K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	5,385	$6K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,185	$6K
86317		<1%	268	$6K
72081		<1%	494	$6K
80377		<1%	269	$6K
92060		<1%	2,332	$6K
83498		<1%	710	$6K
90694		<1%	233	$6K
93246		<1%	410	$6K
84132		<1%	7,740	$6K
82962		<1%	6,782	$6K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	12	$5K
90658		<1%	521	$5K
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	14	$5K
82553		<1%	773	$5K
96131		<1%	139	$5K
27096		<1%	12	$5K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	28,667	$5K
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	1,033	$5K
80362		<1%	2,092	$5K
87088		<1%	5,558	$5K
86431		<1%	3,387	$5K
76514		<1%	275	$5K
97168		<1%	67	$5K
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	<1%	43	$5K
95908		<1%	47	$5K
87493		<1%	455	$5K
86200		<1%	2,368	$5K
82570		<1%	2,467	$5K
82075		<1%	1,123	$5K
83521		<1%	1,468	$5K
80069		<1%	1,316	$5K
86039		<1%	1,666	$5K
86335		<1%	270	$5K
99205	Prolong outpt/office vis	<1%	135	$5K
93261		<1%	32	$5K
90685		<1%	337	$5K
82330		<1%	2,668	$5K
75565		<1%	369	$5K
0082A		<1%	88	$5K
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	2,045	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,154	$5K
87015		<1%	2,642	$4K
81378		<1%	37	$4K
86225		<1%	2,285	$4K
76776		<1%	32	$4K
95012		<1%	620	$4K
73722		<1%	23	$4K
88300		<1%	1,746	$4K
72120		<1%	456	$4K
82985		<1%	1,105	$4K
88172		<1%	372	$4K
87186		<1%	3,426	$4K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	3,881	$4K
72114		<1%	284	$4K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	391	$4K
86364		<1%	1,130	$4K
90461		<1%	1,923	$4K
73523		<1%	457	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	11,645	$4K
C1729	Catheter, drainage	<1%	2,626	$4K
85384		<1%	1,553	$4K
74420		<1%	14	$4K
78306		<1%	15	$4K
74450		<1%	15	$4K
93356		<1%	781	$4K
J3470	Injection, hyaluronidase, up to 150 units	<1%	73	$4K
77077		<1%	206	$4K
90713		<1%	223	$4K
86593		<1%	1,577	$4K
86800		<1%	451	$4K
82140		<1%	1,449	$4K
82397		<1%	947	$4K
83010		<1%	1,010	$3K
86880		<1%	1,304	$3K
86695		<1%	303	$3K
74246		<1%	16	$3K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	2,278	$3K
80175		<1%	487	$3K
87535		<1%	92	$3K
87147		<1%	3,070	$3K
Q0240	Injection, casirivimab and imdevimab, 600 mg	<1%	32	$3K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	677	$3K
74181		<1%	15	$3K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	8,246	$3K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	15	$3K
11056		<1%	14	$3K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	14	$3K
64447		<1%	14	$3K
95115		<1%	82	$3K
86696		<1%	303	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	1,589	$3K
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,910	$3K
83883		<1%	459	$3K
62270		<1%	15	$3K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	7,998	$3K
87634		<1%	94	$3K
51705		<1%	14	$3K
82465		<1%	819	$3K
59426		<1%	23	$3K
83951		<1%	125	$3K
64415		<1%	22	$3K
84436		<1%	961	$3K
0081A		<1%	65	$3K
90655		<1%	279	$2K
84244		<1%	245	$2K
82088		<1%	147	$2K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	170	$2K
83090		<1%	128	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	8,977	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	345	$2K
97129		<1%	94	$2K
J2060	Injection, lorazepam, 2 mg	<1%	3,910	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	5,068	$2K
90611		<1%	79	$2K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	8,514	$2K
11055		<1%	13	$2K
51701		<1%	212	$2K
85007		<1%	658	$2K
0031A		<1%	77	$2K
H0005	Alcohol and/or drug services; group counseling by a clinician	<1%	318	$2K
80201		<1%	204	$2K
70360		<1%	132	$2K
J9370	Vincristine sulfate, 1 mg	<1%	2,697	$2K
86886		<1%	82	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	4,157	$2K
96422		<1%	23	$2K
90630		<1%	163	$2K
85246		<1%	186	$2K
36600		<1%	51	$2K
82310		<1%	1,134	$2K
93299		<1%	47	$2K
72128		<1%	43	$2K
89050		<1%	694	$2K
82024		<1%	70	$2K
88720		<1%	303	$2K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	31	$2K
51702		<1%	54	$2K
83051		<1%	206	$2K
73503		<1%	212	$2K
11721		<1%	424	$2K
85613		<1%	319	$2K
80346		<1%	200	$2K
73565		<1%	221	$2K
86618		<1%	170	$2K
88177		<1%	126	$2K
87449		<1%	109	$1K
90620		<1%	59	$1K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	75	$1K
87338		<1%	230	$1K
84481		<1%	351	$1K
87899		<1%	823	$1K
G0460	Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment	<1%	40	$1K
0083A		<1%	23	$1K
86301		<1%	216	$1K
82375		<1%	1,523	$1K
91313		<1%	196	$1K
86705		<1%	310	$1K
93923		<1%	14	$1K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	6,891	$1K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	6,041	$1K
80299		<1%	272	$1K
97130		<1%	51	$1K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,673	$1K
86308		<1%	631	$1K
90632		<1%	42	$1K
84155		<1%	1,169	$1K
82274		<1%	202	$1K
76857		<1%	18	$1K
85240		<1%	189	$1K
J1815	Injection, insulin, per 5 units	<1%	4,587	$1K
88230		<1%	29	$1K
73522		<1%	127	$1K
C1788	Port, indwelling (implantable)	<1%	588	$1K
91303		<1%	74	$1K
87140		<1%	199	$972.46
72192		<1%	14	$961.87
99381		<1%	18	$954.80
95983		<1%	12	$947.50
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	3,074	$945.11
87101		<1%	257	$942.55
84445		<1%	61	$909.57
Q3014	Telehealth originating site facility fee	<1%	634	$896.78
84295		<1%	2,268	$878.13
82164		<1%	95	$867.97
C2617	Stent, non-coronary, temporary, without delivery system	<1%	190	$861.00
81267		<1%	17	$841.98
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	483	$841.06
80349		<1%	179	$832.76
82955		<1%	193	$815.63
A4663	Blood pressure cuff only	<1%	2,032	$791.29
92285		<1%	67	$779.28
J0280	Injection, aminophyllin, up to 250 mg	<1%	782	$765.66
76376		<1%	216	$751.07
J7999	Compounded drug, not otherwise classified	<1%	2,461	$731.61
J9196	Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg	<1%	20	$729.72
J0461	Injection, atropine sulfate, 0.01 mg	<1%	344	$725.24
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	4,210	$716.84
80230		<1%	301	$710.97
83718		<1%	267	$689.79
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	886	$688.91
90678		<1%	20	$683.10
23350		<1%	49	$679.89
88112		<1%	98	$675.18
90739		<1%	19	$673.34
0013A		<1%	31	$667.93
J1630	Injection, haloperidol, up to 5 mg	<1%	1,809	$661.84
84166		<1%	107	$661.11
82435		<1%	1,974	$657.78
88299		<1%	24	$653.05
87506		<1%	12	$651.97
84300		<1%	477	$642.07
85347		<1%	285	$632.08
80195		<1%	18	$562.48
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,272	$543.31
80158		<1%	82	$541.93
84157		<1%	610	$505.72
96118		<1%	46	$504.21
93289		<1%	12	$502.74
84681		<1%	112	$495.95
84478		<1%	384	$493.87
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	2,446	$489.23
80339		<1%	32	$482.87
G0010	Administration of hepatitis b vaccine	<1%	87	$480.63
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	147	$477.65
86146		<1%	122	$474.60
70030		<1%	28	$473.74
84590		<1%	106	$467.64
93280		<1%	17	$466.18
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	641	$464.22
84446		<1%	120	$449.84
83930		<1%	416	$445.13
85732		<1%	315	$440.16
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,029	$439.70
J0572	Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine	<1%	46	$435.94
C1760	Closure device, vascular (implantable/insertable)	<1%	1,322	$433.01
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,729	$424.13
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	53	$422.81
82945		<1%	385	$400.40
90680		<1%	139	$397.60
87110		<1%	222	$387.19
C1750	Catheter, hemodialysis/peritoneal, long-term	<1%	95	$377.25
94761		<1%	2,631	$367.74
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	108	$362.84
H0004	Behavioral health counseling and therapy, per 15 minutes	<1%	36	$338.50
73660		<1%	45	$336.00
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	158	$332.93
94664		<1%	341	$326.13
87206		<1%	385	$326.03
83050		<1%	1,300	$323.46
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,424	$312.77
86769		<1%	108	$309.17
83721		<1%	176	$303.52
72020		<1%	57	$299.65
80235		<1%	109	$299.41
82239		<1%	28	$295.37
73650		<1%	14	$288.61
80358		<1%	153	$284.96
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	2,689	$281.43
73501		<1%	67	$277.81
86341		<1%	29	$271.77
87255		<1%	18	$266.25
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	1,559	$265.24
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	119	$263.34
88346		<1%	16	$262.26
C9113	Injection, pantoprazole sodium, per vial	<1%	1,915	$259.60
83695		<1%	61	$245.64
84479		<1%	58	$239.15
86765		<1%	17	$232.61
86735		<1%	17	$211.14
85014		<1%	181	$208.29
86920		<1%	163	$208.03
J1836	Injection, metronidazole, 10 mg	<1%	717	$186.50
87045		<1%	62	$185.34
G0451	Development testing, with interpretation and report, per standardized instrument form	<1%	12	$183.37
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	52	$179.47
69209		<1%	173	$177.58
72080		<1%	14	$173.94
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	348	$165.73
86008		<1%	78	$165.70
0134A		<1%	20	$164.70
A4215	Needle, sterile, any size, each	<1%	356	$162.64
86645		<1%	14	$160.19
82107		<1%	70	$159.65
84255		<1%	29	$154.61
83835		<1%	31	$154.32
84145		<1%	214	$153.52
86580		<1%	15	$140.33
71100		<1%	32	$137.17
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	234	$131.22
87046		<1%	63	$127.91
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	261	$125.86
89060		<1%	82	$123.14
80373		<1%	14	$121.42
88333		<1%	95	$119.82
V2632	Posterior chamber intraocular lens	<1%	930	$116.19
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	422	$113.26
86258		<1%	69	$105.66
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,788	$101.88
85660		<1%	1,259	$99.91
82340		<1%	28	$98.91
88334		<1%	103	$96.41
80165		<1%	13	$95.85
86361		<1%	47	$95.83
87350		<1%	27	$94.34
80156		<1%	23	$94.33
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	1,793	$90.48
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	663	$89.38
87324		<1%	54	$88.20
C1819	Surgical tissue localization and excision device (implantable)	<1%	2,693	$87.49
C1755	Catheter, intraspinal	<1%	209	$84.41
J9260	Injection, methotrexate sodium, 50 mg	<1%	356	$81.34
83519		<1%	18	$80.57
86707		<1%	15	$77.98
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,978	$74.76
88331		<1%	14	$74.02
87181		<1%	14	$67.72
86037		<1%	49	$67.36
87176		<1%	517	$64.09
87106		<1%	37	$61.94
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	15	$60.45
J9250	Methotrexate sodium, 5 mg	<1%	71	$56.38
91311		<1%	13	$54.51
91317		<1%	17	$54.50
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	630	$53.06
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	961	$49.13
88240		<1%	19	$47.18
86677		<1%	14	$44.42
90380		<1%	14	$44.15
J9267	Injection, paclitaxel, 1 mg	<1%	358	$43.82
46600		<1%	14	$43.70
85306		<1%	18	$42.36
S0077	Injection, clindamycin phosphate, 300 mg	<1%	136	$40.18
A4649	Surgical supply; miscellaneous	<1%	122	$38.88
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,610	$35.34
82374		<1%	35	$34.58
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	13	$34.48
82077		<1%	30	$28.90
S5010	5% dextrose and 0.45% normal saline, 1000 ml	<1%	764	$27.31
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	483	$26.65
85303		<1%	13	$25.77
81000		<1%	168	$25.67
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	1,097	$22.29
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,711	$19.32
86403		<1%	13	$16.66
99070		<1%	1,575	$16.20
94760		<1%	599	$15.92
84560		<1%	19	$14.78
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	886	$13.95
80047		<1%	31	$10.38
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	66	$9.87
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	73	$8.64
82010		<1%	13	$8.49
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	65	$8.02
J1171	Injection, hydromorphone, 0.1 mg	<1%	526	$7.59
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	745	$7.41
A4550	Surgical trays	<1%	77	$4.62
L8613	Ossicula implant	<1%	437	$0.33
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	416	$0.32
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	129	$0.00
C1733	Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip	0%	15	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	35	$0.00
99220		0%	23	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	206	$0.00
D7140	Extraction, erupted tooth or exposed root	0%	67	$0.00
A4648	Tissue marker, implantable, any type, each	0%	306	$0.00
J1805	Injection, esmolol hydrochloride, 10 mg	0%	148	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	59	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	49	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	63	$0.00
D1206	Topical application of fluoride varnish	0%	18	$0.00
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	0%	44	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	909	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	16	$0.00
D1351	Sealant - per tooth	0%	16	$0.00
71101		0%	13	$0.00
A4300	Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access	0%	28	$0.00
J0611	Injection, calcium gluconate (wg critical care), per 10 ml	0%	16	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	37	$0.00
99156		0%	31	$0.00
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	0%	29	$0.00
J7507	Tacrolimus, immediate release, oral, 1 mg	0%	32	$0.00
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	0%	15	$0.00
D2930	Prefabricated stainless steel crown - primary tooth	0%	92	$0.00
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	0%	254	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	1,026	$0.00
J1598	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	0%	106	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	84	$0.00
C1776	Joint device (implantable)	0%	401	$0.00
99157		0%	15	$0.00
C1874	Stent, coated/covered, with delivery system	0%	63	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	498	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	367	$0.00
J7070	Infusion, d5w, 1000 cc	0%	390	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	62	$0.00
J7510	Prednisolone oral, per 5 mg	0%	65	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	41	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	105	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	310	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	156	$0.00
D1120	Dental cleaning, child	0%	29	$0.00
C1758	Catheter, ureteral	0%	50	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	152	$0.00
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	0%	14	$0.00
S0028	Injection, famotidine, 20 mg	0%	90	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	40	$0.00
Q9956	Injection, octafluoropropane microspheres, per ml	0%	15	$0.00
C1757	Catheter, thrombectomy/embolectomy	0%	16	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARLAN, ELIZABETH (REVENUE CYCLE DIRECTOR)

Same official

Other billing entities under HARLAN, ELIZABETH

Full network →

Provider	Location	Paid
Community Memorial Hospital	South Hill, VA	$35.67M
Vcu Health Tappahannock Hospital	Tappahannock, VA	$20.60M
Virginia Commonwealth University Health System Authority	Richmond, VA	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.